HealthEquity (NASDAQ:HQY) Reaches New 52-Week High - What's Next?

HealthEquity, Inc. (NASDAQ:HQY - Get Free Report) shares hit a new 52-week high on Monday . The stock traded as high as $100.88 and last traded at $99.14, with a volume of 30915 shares. The stock had previously closed at $98.82.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on HQY. Deutsche Bank Aktiengesellschaft lifted their price target on HealthEquity from $102.00 to $103.00 and gave the company a "buy" rating in a research report on Wednesday, September 4th. Royal Bank of Canada reiterated an "outperform" rating and set a $92.00 price objective on shares of HealthEquity in a research report on Wednesday, September 4th. JMP Securities reiterated a "market outperform" rating and set a $105.00 target price on shares of HealthEquity in a research report on Wednesday, September 4th. Bank of America lowered their price objective on HealthEquity from $105.00 to $100.00 and set a "buy" rating for the company in a research note on Wednesday, September 4th. Finally, Barrington Research reaffirmed an "outperform" rating and issued a $105.00 price objective on shares of HealthEquity in a research note on Friday, September 20th. Twelve investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock has an average rating of "Buy" and a consensus price target of $103.83.

HealthEquity Price Performance

The stock has a 50-day moving average price of $83.57 and a two-hundred day moving average price of $80.60. The company has a current ratio of 4.10, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51. The stock has a market cap of $8.76 billion, a price-to-earnings ratio of 83.56, a PEG ratio of 1.55 and a beta of 0.52.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its quarterly earnings data on Tuesday, September 3rd. The company reported $0.66 EPS for the quarter, topping the consensus estimate of $0.50 by $0.16. The company had revenue of $299.93 million during the quarter, compared to analyst estimates of $284.48 million. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. As a group, equities research analysts forecast that HealthEquity, Inc. will post 2.27 EPS for the current year.

Insider Activity at HealthEquity

In related news, Director Robert W. Selander sold 8,250 shares of the company's stock in a transaction that occurred on Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total value of $684,585.00. Following the transaction, the director now directly owns 54,719 shares in the company, valued at approximately $4,540,582.62. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, Director Frank Corvino sold 1,039 shares of the stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total value of $99,847.90. Following the transaction, the director now owns 3,784 shares of the company's stock, valued at $363,642.40. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Robert W. Selander sold 8,250 shares of the stock in a transaction on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total value of $684,585.00. Following the completion of the transaction, the director now directly owns 54,719 shares in the company, valued at $4,540,582.62. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 10,536 shares of company stock worth $884,517. Insiders own 2.20% of the company's stock.

Hedge Funds Weigh In On HealthEquity

Hedge funds have recently made changes to their positions in the company. International Assets Investment Management LLC acquired a new position in HealthEquity during the 2nd quarter worth approximately $35,000. Paladin Wealth LLC purchased a new stake in shares of HealthEquity during the 3rd quarter worth approximately $39,000. GAMMA Investing LLC boosted its stake in shares of HealthEquity by 114.8% during the 2nd quarter. GAMMA Investing LLC now owns 595 shares of the company's stock worth $51,000 after acquiring an additional 318 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of HealthEquity during the 2nd quarter worth approximately $73,000. Finally, 1620 Investment Advisors Inc. purchased a new stake in HealthEquity in the 3rd quarter valued at approximately $112,000. Hedge funds and other institutional investors own 99.55% of the company's stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.